全球口咽念珠菌念珠菌症市場按類型、治療、給藥途徑、分銷管道和地區分類

Global Oropharyngeal Candidiasis Market, By Type, By Treatment, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2025年03月04日 | 出版商:

Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球口咽念珠菌症市場規模估計為 4.564 億美元，預計到 2032 年將達到 6.128 億美元，2025 年至 2032 年的複合年成長率為 4.3%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	4.564億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	4.30%	2032年價值預測	6.128億美元

數字。 2025年全球口咽念珠菌症各地區全球市場佔有率（%）

口咽念珠菌症（OPC），通常也稱為鵝口瘡，是由口腔和喉嚨黏膜中念珠菌屬（主要是白色念珠菌）過度生長引起的真菌感染疾病。念珠菌是口腔微生物群的正常組成部分，但在某些條件下，微生物的微妙平衡會被打破，導致念珠菌過度生長。它在免疫系統較弱的人群中更為常見，例如患有人類免疫力缺乏病毒/後天免疫力缺乏症候群（愛滋病毒/愛滋病）的人、正在接受化療的人和服用廣譜抗生素的人。糖尿病患者、服用皮質類固醇的人和戴假牙的人也可能出現這種情況。感染疾病的典型特徵是舌頭、臉頰內側、口腔頂部、牙齦、扁桃體和喉嚨後部出現白斑。這些病灶可能會略微凸起，在嚴重的情況下，可能會導致不適或吞嚥困難。念珠菌症是一種在免疫力缺乏的人群中廣泛傳播的疾病，引起了醫學研究和患者照護的廣泛關注。念珠菌是口腔菌叢的正常組成部分，對大多數人無害，但免疫力缺乏、長期使用抗生素、糖尿病和某些醫療等各種情況都可能使人容易罹患這種機會性真菌感染疾病。這種感染疾病的特徵性症狀是口腔和喉嚨黏膜表面出現乳白色病變。這些病變可能會讓人感到不舒服，如果病灶範圍較大，可能會影響正常進食和吞嚥。 OPC 的治療通常涉及抗真菌藥物，並專注於解決可能導致真菌過度生長的任何潛在疾病。市場分析顯示，該疾病治療領域受到全球糖尿病和愛滋病毒/愛滋病高發病率的嚴重影響，導致對有效抗真菌療法的需求增加。

市場動態：

全球口咽念珠菌症市場受到愛滋病毒/愛滋病盛行率上升以及更容易受到真菌感染疾病的老年人口增加的推動。此外，日益激進的腫瘤導向治療以及頻譜抗生素和皮質類固醇治療的頻繁使用加劇了鵝口瘡的風險。然而，市場可能面臨學名藥競爭加劇和替代治療方案可用性等限制因素。

本研究的主要特點

本報告對全球口咽念珠菌症市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和複合年成長率。
它還強調了各個領域的潛在商機，並說明了該市場的引人注目的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數列出了全球口咽念珠菌症市場的主要企業簡介。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興車型、市場擴張和行銷策略做出明智的決策。
全球口咽念珠菌念珠菌症市場報告涉及該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員將透過用於分析全球口咽念珠菌症市場的各種策略矩陣更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 456.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	4.30%	2032 Value Projection:	USD 612.8 Mn

Oropharyngeal candidiasis (OPC) which is also commonly known as oral thrush, is a fungal infection which is caused by the overgrowth of Candida species, predominantly Candida albicans, in the oral and pharyngeal mucous membranes. While Candida is a normal component of the oral microbiota, certain conditions can disrupt the delicate balance of microorganisms, thereby leading to its excessive proliferation. It is frequently observed in individuals with compromised immune systems, such as those with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), undergoing chemotherapy, or taking broad-spectrum antibiotics. It can also occur in patients with diabetes or those who use corticosteroids or wear dentures. The infection is typically characterized by white patches on the tongue, inner cheeks, and roof of the mouth, gums, tonsils, or the back of the throat. These lesions can be slightly raised and may cause discomfort or difficulty in swallowing when severe. It is a condition that has garnered significant attention within medical research and patient care due to its pervasive nature in immunocompromised populations. While Candida is a standard tenant of the oral flora among many individuals without causing harm, various circumstances, such as immunodeficiency, extended antibiotic use, diabetes, and certain medical therapies, can predispose individuals to this opportunistic fungal infection. The hallmark symptoms of this infection consist of creamy white lesions that appear on the mucosal surfaces of the oral cavity and the throat. These lesions are sometimes accompanied by discomfort and can impede proper nutrition and swallowing when they are extensive. The treatment landscape for OPC typically involves antifungal medications, with an emphasis on addressing any underlying conditions that may have led to the fungal overgrowth. Market analysis reveals that the therapeutic area for this condition is significantly influenced by the high prevalence of diabetes and HIV/AIDS globally, with a resultant increase in demand for efficacious antifungal therapies.

Market Dynamics:

Global oropharyngeal candidiasis market is driven by the rising prevalence of HIV/AIDS along with a growing elderly population that is susceptible to fungal infections. Moreover, increasingly aggressive tumor-directed therapies along with frequent use of broad-spectrum antibiotic and corticosteroid therapies spur the risk of oral thrush. However, the market potentially faces restraints from rising generics competition and availability of alternate treatment options.

Key features of the study:

This report provides in-depth analysis of the global oropharyngeal candidiasis market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global oropharyngeal candidiasis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Bayer AG, Teva Pharmaceuticals, Stellar Pharma, Pfizer, Wockhardt, Ranbaxy Laboratories, Bristol Laboratories, Glenmark Pharmaceuticals Ltd, and GlaxoSmithKline.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global oropharyngeal candidiasis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oropharyngeal candidiasis market.

Detailed Segmentation:

Global Oropharyngeal Candidiasis Market, By Type
- Pseudomembranous
- Erythematous
- Hyperplastic
Global Oropharyngeal Candidiasis Market, By Treatment
- Anti-fungal
- Immune-modulators
Global Oropharyngeal Candidiasis Market, By Route of Administration
- Oral
- Topical
- Others
Global Oropharyngeal Candidiasis Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Oropharyngeal Candidiasis Market, By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Bayer AG
- Teva Pharmaceuticals
- Stellar Pharma
- Pfizer
- Wockhardt
- Ranbaxy Laboratories
- Bristol Laboratories
- Glenmark Pharmaceuticals Ltd
- GlaxoSmithKline

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Oropharyngeal Candidiasis, By Type
- Market Oropharyngeal Candidiasis, By Treatment
- Market Oropharyngeal Candidiasis, By Route of Administration
- Market Oropharyngeal Candidiasis, By Distribution Channel
- Market Oropharyngeal Candidiasis, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
Increasing prevalence of HIV/AIDS
Rising research funding and projects
Increasing number of healthcare facilities
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Global Oropharyngeal Candidiasis Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Oropharyngeal Candidiasis Market, By Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pseudomembranous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Erythematous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Hyperplastic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Oropharyngeal Candidiasis Market, By Treatment, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Anti-fungal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Immune-modulators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Oropharyngeal Candidiasis Market, By Route of Administration, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Oropharyngeal Candidiasis Market, By Distribution Channel, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

9. Global Oropharyngeal Candidiasis Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032 ,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Mn)
  - South Africa
  - North Africa
  - Central Africa